ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

WellBeam closes $10 Million Series A to Transform Clinical Interoperability and Care Coordination between Acute and Post-Acute Providers

REDWOOD CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- WellBeam, a healthcare technology company dedicated to improving clinical care management between acute and post-acute parties through seamless interoperability and electronic medical record (EMR) integration, today announced it has raised $10 million in Series A funding. The round was led by Wittington Ventures and includes participation from F-Prime, Advocate Health, and Oncology Ventures. The funding accelerates WellBeam’s growth, expanding its interoperability infrastructure across health systems, physician groups, and post-acute partners to break down EMR data silos and enable next-generation solutions for coordinated patient care.

“Healthcare systems are under increasing pressure to deliver high-quality, cost-effective care as patients move across care settings,” said Megh Gupta, managing partner at Wittington Ventures. “WellBeam’s connected provider network and EMR-integrated workflows directly address the longstanding interoperability challenges that have limited progress in this area. We’re excited to back WellBeam as they scale this critical infrastructure to providers and their patients nationwide.”

WellBeam provides interoperability solutions that connect acute and post-acute providers. These solutions enable streamlined clinical workflows and improved care coordination, all from within the user’s EMR. WellBeam’s platform transforms patient care across the continuum whilst driving financial top line improvement and a reduction in administrative overhead for clinical teams overseeing post-acute care.

“The transition from a hospital or ambulatory care setting to home is a crucial stage in a patient’s care journey. Despite this, clinical data isn’t exchanged seamlessly between EMRs to support best-in-class quality of care and clinical efficiency along these transitions,” said Amee Devani, chief executive officer and co-founder of WellBeam. “By accelerating network and data infrastructure connecting acute to post-acute provider networks, this investment unlocks a vast number of clinical use cases that rely on this seamless exchange of information and clinical data.”

WellBeam’s customers, including health systems, physician networks, independent medical groups, and their post-acute partners, have achieved the highly desired “triple bottom line” return: a 25% reduction in unplanned post-acute care, 75% decrease in manual clinical workflows, and new top-line revenue growth.

“We’re proud to partner with forward-thinking companies like WellBeam that are building the critical infrastructure needed to connect care across settings,” said Brett Cook, partner at F-Prime. “Seamless data movement is the foundation for solutions that transform care delivery and clinical workflows across the continuum. We’re excited to support the WellBeam team as they enter their next phase of growth.”

To learn more about WellBeam’s solutions and measurable impact, or to schedule a demo, visit www.well-beam.com.

About WellBeam
WellBeam is a healthcare technology company that improves how data and workflows move between acute and post-acute care providers. It enables care teams to complete key clinical tasks directly from within their EMR while connecting data and information between different EMRs. This seamless exchange of information supports better patient care, greater efficiency, and stronger financial performance. Learn more at www.well-beam.com.

About Wittington Ventures
Wittington Ventures is a $500M multi-stage investment platform that backs transformative companies across the consumer, commerce, healthcare, and climate sectors. Backed by Wittington Investments—the controlling shareholder of Loblaw, Shoppers Drug Mart, and Choice Properties—the firm leverages its proprietary industry access, philanthropic research insights, and long-term capital to support founders throughout their growth journey.

Media Contacts
wellbeam@v2comms.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.